X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs VENUS REMEDIES - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH VENUS REMEDIES STERLING BIOTECH/
VENUS REMEDIES
 
P/E (TTM) x -1.8 -841.0 - View Chart
P/BV x 0.1 0.2 27.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   VENUS REMEDIES
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
VENUS REMEDIES
Mar-16
STERLING BIOTECH/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs11218 4.8%   
Low Rs382 4.1%   
Sales per share (Unadj.) Rs26.8365.6 7.3%  
Earnings per share (Unadj.) Rs-15.01.5 -1,006.5%  
Cash flow per share (Unadj.) Rs-5.537.9 -14.4%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9382.5 14.3%  
Shares outstanding (eoy) m267.8711.44 2,341.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 63.2%   
Avg P/E ratio x-0.5101.0 -0.5%  
P/CF ratio (eoy) x-1.34.0 -32.2%  
Price / Book Value ratio x0.10.4 32.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,717 108.5%   
No. of employees `0001.41.0 132.7%   
Total wages/salary Rs m547324 168.6%   
Avg. sales/employee Rs Th5,303.34,100.7 129.3%   
Avg. wages/employee Rs Th403.8318.0 127.0%   
Avg. net profit/employee Rs Th-2,959.016.7 -17,754.1%   
INCOME DATA
Net Sales Rs m7,1814,183 171.7%  
Other income Rs m4320 211.9%   
Total revenues Rs m7,2234,203 171.9%   
Gross profit Rs m947812 116.7%  
Depreciation Rs m2,543417 610.2%   
Interest Rs m4,377380 1,152.5%   
Profit before tax Rs m-5,93135 -16,896.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92418 -10,631.5%   
Profit after tax Rs m-4,00717 -23,567.6%  
Gross profit margin %13.219.4 68.0%  
Effective tax rate %32.451.6 62.9%   
Net profit margin %-55.80.4 -13,728.0%  
BALANCE SHEET DATA
Current assets Rs m14,3352,771 517.4%   
Current liabilities Rs m49,8091,931 2,579.0%   
Net working cap to sales %-494.020.1 -2,461.9%  
Current ratio x0.31.4 20.1%  
Inventory Days Days403125 322.6%  
Debtors Days Days17154 317.5%  
Net fixed assets Rs m55,4325,328 1,040.3%   
Share capital Rs m268114 234.2%   
"Free" reserves Rs m13,9354,177 333.6%   
Net worth Rs m14,7014,376 335.9%   
Long term debt Rs m9,4781,911 496.1%   
Total assets Rs m73,9888,428 877.9%  
Interest coverage x-0.41.1 -32.5%   
Debt to equity ratio x0.60.4 147.7%  
Sales to assets ratio x0.10.5 19.6%   
Return on assets %0.54.7 10.6%  
Return on equity %-27.30.4 -7,015.6%  
Return on capital %-6.46.6 -97.4%  
Exports to sales %25.90-   
Imports to sales %0.220.5 0.8%   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12858 1.4%   
Fx inflow Rs m1,8600-   
Fx outflow Rs m25858 2.9%   
Net fx Rs m1,835-858 -213.8%   
CASH FLOW
From Operations Rs m1,719469 366.6%  
From Investments Rs m-3,14829 -10,781.5%  
From Financial Activity Rs m1,426-464 -307.7%  
Net Cashflow Rs m-335 -9.9%  

Share Holding

Indian Promoters % 33.9 32.9 103.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 9.9 0.6 1,706.9%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 66.4 59.2%  
Shareholders   21,482 20,121 106.8%  
Pledged promoter(s) holding % 55.9 36.4 153.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  FULFORD INDIA  ALEMBIC PHARMA  AJANTA PHARMA  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

Tata Chemicals: Profits remain flat (Quarterly Results Update - Detailed)

Nov 19, 2015

Tata Chemicals has reported consolidated topline growth of 4% YoY while the bottomline has fallen 0.8% YoY.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Aug 17, 2017 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS